Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Mitomycin price, strengths & recalls

Mitomycin has no weekly pharmacy acquisition cost. 6 manufacturers make it. 1 recall is ongoing. Its official label last changed on June 15, 2023.

1 open recallGeneric
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Mitomycin price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
5 mg injectionNot priced this week
40 mg injectionNot priced this week

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
1 ongoing recall39 recalls on record, latest Feb 1, 2023

Recalls

Showing the 6 most relevant of 39 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for mitomycin? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 15, 2023
Version1
EffectiveMay 24, 2023
Read the label

MITOMYCIN FOR INJECTION, USP40 mg per vial(For Intravenous Use)

This drug has a boxed warning

WARNING

Mitomycin should be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. Appropriate management of therapy and complications is possible only when adequate diagnostic and treatment facilities are readily available.

Bone marrow suppression, notably thrombocytopenia and leukopenia, which may contribute to overwhelming infections in an already compromised patient, is the most common and severe of the toxic effects of mitomycin (see WARNINGS and ADVERSE REACTIONS sections).

Hemolytic Uremic Syndrome (HUS) a serious complication of chemotherapy, consisting primarily of microangiopathic hemolytic anemia, thrombocytopenia, and irreversible renal failure has been reported in patients receiving systemic mitomycin. The syndrome may occur at any time during systemic therapy with mitomycin as a single agent or in combination with other cytotoxic drugs, however, most cases occur at doses ≥60 mg of mitomycin. Blood product transfusion may exacerbate the symptoms associated with this syndrome.

The incidence of the syndrome has not been defined.

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Generic makers
3 approved generic applications on the market

Mitomycin questions

Is mitomycin in shortage?

No shortage is reported for mitomycin right now. We check the national shortage list every day.

Has mitomycin been recalled?

39 recalls on record, 1 ongoing. Recalls name specific lots - check yours.

When did the mitomycin label last change?

The official label was last updated on June 15, 2023 (version 1). See what changed.

Talk about mitomycin

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.